BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2003
View Archived Issues
BENEFIT study in early MS completes enrollment
Read More
Encouraging phase II efficacy results for NCX-701 in acute pain
Read More
XL-784 enters first-in-man safety study
Read More
DOR BioPharma pursues second indication for orBec
Read More
ES-285 enters clinical development
Read More
Good safety profile and improved glycemic control reported for balaglitazone in type 2 diabetes
Read More
Rapid onset of action reported for a novel insulin analogue
Read More
Excellent treatment compliance reported for AERx(R) iDMS among diabetic patients
Read More
Dose-dependent improvements in glycemic control in diabetic rats and humans treated with exenatide
Read More
Pramlintide acetate improves glycemic control without increasing body weight
Read More
New LXR ligands and their use described by Merck researchers
Read More
Celltech scientists design novel p38 inhibitors for arthritis and other disorders
Read More
Yamanouchi prepares and tests new vasopressin V2 ligands
Read More
Isatoribine derivatives with improved pharmacokinetics reported by Anadys
Read More
GSK-3 inhibitors, their preparation and use covered by GSK patent
Read More
New antiestrogenic agents in early development at Schering AG
Read More
Two series of beta-secretase inhibitors revealed in recent patents
Read More
Novel inhibitors of CD23 production with utility in allergy, asthma, etc.
Read More
ZP-123 prevents ischemia-induced ventricular tachycardia via effects on gap junctions
Read More
Sterix presents first dual aromatase and steroid sulfatase inhibitor
Read More
Novel aquaretic and antivasopressor agent targeting both V1a and V2 receptors
Read More
Orally active nonsteroidal progesterone receptor antagonist PRA-248 characterized
Read More
FDA approves Reyataz for HIV-1 infection
Read More
FDA approval of Striant for testosterone replacement therapy
Read More
First humanized IgE-targeting antibody therapeutic approved for asthma
Read More
Manhattan and NovaDel begin propofol lingual spray program
Read More
Emisphere and U.S. Army sign CRADA for oral anthrax vaccine
Read More
VIC-acne completes phase I safety study
Read More
